Epidemiology, characteristics, and outcome of infective endocarditis in Italy: The Italian Study on Endocarditis

Infection

Volumn 40, Issue 5, 2012, Pages 527-535

  Leone, S ^a   Ravasio, V ^a   Durante Mangoni, E ^b   Crapis, M ^c   Carosi, G ^d   Scotton, P G ^e   Barzaghi, N ^f   Falcone, M ^g   Chinello, P ^h   Pasticci, M B ⁱ   Grossi, P ^j   Utili, R ^b   Viale, P ^k   Rizzi, M ^a   Suter, F ^a  

^a OSPEDALI RIUNITI   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e OSPEDALE CA FONCELLO   (Italy)

^f S CROCE E CARLE HOSPITAL   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

ⁱ UNIVERSITY OF PERUGIA   (Italy)

^j UNIVERSITY OF INSUBRIA   (Italy)

^k UNIVERSITY OF BOLOGNA   (Italy)

more..

Author keywords

Characteristics; Epidemiology; Infective endocarditis; Italy; Outcome

Indexed keywords

ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CEREBROVASCULAR ACCIDENT; CHRONIC LIVER DISEASE; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; ENTEROCOCCUS; FEMALE; HOSPITAL INFECTION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; PROGNOSIS; PROSPECTIVE STUDY; PROSTHESIS INFECTION; RISK FACTOR; STAPHYLOCOCCUS AUREUS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867744315     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-012-0285-y     Document Type: Article

References (29)

1. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345:1318-30.
2. Moreillon P, Que YA. Infective endocarditis. Lancet. 2004;363: 139-49.
3. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH; International Collaboration on Endocarditis- Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis- Prospective Cohort Study. Arch Intern Med. 2009;169:463-73.
4. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633-8.
5. Wilson WR, Jaumin PM, Danielson GK, Giuliani ER, Washington JA II, Geraci JE. Prosthetic valve endocarditis. Ann Intern Med. 1975;82:751-6.
6. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, Lande G, Lazarus A, Victor J, Barnay C, Grandbastien B, Kacet S; PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116:1349-55.
7. Chirillo F, Bacchion F, Pedrocco A, Scotton P, De Leo A, Rocco F, Valfrè C, Olivari Z. Infective endocarditis in patients with diabetes mellitus. J Heart Valve Dis. 2010;19:312-20.
8. Bishara J, Peled N, Samra Z, Sagie A, Leibovici L, Pitlik S. Infective endocarditis in diabetic and non-diabetic patients. Scand J Infect Dis. 2004;36:795-8.
9. Moreno R, Zamorano J, Almería C, Villate A, Rodrigo JL, Herrera D, Alvarez L, Morán J, Aubele A, Mataix L, De Marco E, Sánchez- Harguindey L. Influence of diabetes mellitus on short- and long-term outcome in patients with active infective endocarditis. J Heart Valve Dis. 2002;11:651-9.
10. Tripodi MF, Adinolfi LE, Ragone E, Durante Mangoni E, Fortunato R, Iarussi D, Ruggiero G, Utili R. Streptococcus bovis endocarditis and its association with chronic liver disease: an underestimated risk factor. Clin Infect Dis. 2004;38:1394-400.
11. Fernández Guerrero ML, González López J, Górgolas M. Infectious endocarditis in patients with cirrhosis of the liver: a model of infection in the frail patient. Eur J Clin Microbiol Infect Dis. 2010;29:1271-5.
12. Cesaro C, Tiso A, Del Prete A, Cariello R, Tuccillo C, Cotticelli G, Del Vecchio Blanco C, Loguercio C. Gut microbiota and probiotics in chronic liver diseases. Dig Liver Dis. 2011;43:431-8.
13. Netzer RO, Zollinger E, Seiler C, Cerny A. Native valve infective endocarditis in elderly and younger adult patients: comparison of clinical features and outcomes with use of the Duke criteria. Clin Infect Dis. 1999;28:933-5.
14. Dhawan VK. Infective endocarditis in elderly patients. Clin Infect Dis. 2002;34:806-12.
15. Anderson HJ, Staffurth JS. Subacute bacterial endocarditis in the elderly. Lancet. 1955;269:1055-8.
16. Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, Cabell CH, Ramos AI, Fowler V Jr, Hoen B, Koneçny P, Moreno A, Murdoch D, Pappas P, Sexton DJ, Spelman D, Tattevin P, Miró JM, van der Meer JT, Utili R; International Collaboration on Endocarditis Prospective Cohort Study Group. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med. 2008;168: 2095-103.
17. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS; ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;293:3012-21.
18. Benito N, Miró JM, de Lazzari E, Cabell CH, del Río A, Altclas J, Commerford P, Delahaye F, Dragulescu S, Giamarellou H, Habib G, Kamarulzaman A, Kumar AS, Nacinovich FM, Suter F, Tribouilloy C, Venugopal K, Moreno A, Fowler VG Jr; ICE-PCS (International Collaboration on Endocarditis Prospective Cohort Study) Investigators. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med. 2009;150:586-94.
19. Scudeller L, Badano L, Crapis M, Pagotto A, Viale P. Populationbased surveillance of infectious endocarditis in an Italian region. Arch Intern Med. 2009;169:1720-3.
20. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA. 2003;289:1933-40.
21. San Román JA, López J, Vilacosta I, Luaces M, Sarriá C, Revilla A, Ronderos R, Stoermann W, Gómez I, Fernández- Avilés F. Prognostic stratification of patients with left-sided endocarditis determined at admission. Am J Med. 2007;120:369.e1-7.
22. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Müller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL; ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369-413.
23. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; Council on Cardiovascular Disease in the Young; Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia; American Heart Association; Infectious Diseases Society of America. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111: e394-434.
24. Sexton DJ, Spelman D. Current best practices and guidelines. Assessment and management of complications in infective endocarditis. Cardiol Clin. 2003;21:273-82.
25. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA. 2003;290:3207-14.
26. Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, Wilson WR, Baddour LM. A systematic review of population-based studies of infective endocarditis. Chest. 2007;132:1025-35.
27. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Montori VM, Hoskin TL, Enders F, Huskins WC, Mookadam F, Wilson WR, Zimmerman V, Baddour LM. Propensity score analysis with a time-dependent intervention is an acceptable although not an optimal analytical approach when treatment selection bias and survivor bias coexist. J Clin Epidemiol. 2010;63:139-40.
28. Austin PC, Platt RW. Survivor treatment bias, treatment selection bias, and propensity scores in observational research. J Clin Epidemiol. 2010;63:136-8.
29. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Montori VM, Hoskin TL, Enders F, Huskins WC, Mookadam F, Wilson WR, Zimmerman V, Baddour LM. Conclusion about the association between valve surgery and mortality in an infective endocarditis cohort changed after adjusting for survivor bias. J Clin Epidemiol. 2010;63:130-5.